Completed PHASE1 INTERVENTIONAL 1-arm NCT02068872

Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation

Pilot Study to Assess the Feasibility, Safety and Tolerability of Sleeve Gastrectomy in Morbidly Obese Patients Undergoing Orthotopic Liver Transplantation

Sponsor: Northwestern University

Conditions Cardiovascular Disease Complication of Transplant Hypertension Obesity Type 2 Diabetes

Interventions Sleeve Gastrectomy

Updated 6 times since 2017 Last updated: Sep 30, 2015 Started: Feb 28, 2014 Primary completion: May 31, 2014 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Cardiovascular Disease and Complication of Transplant and is currently completed. Northwestern University leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States